Swiss National Bank

Swiss National Bank’s Esperion Therapeutics ESPR Stock Holding History

Swiss National Bank’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-172,500	Closed	-$274K	–	2621
2023 Q1	$274K	Buy	172,500 +35,900	+26%	+$185K	﹤0.01%	2619
2022 Q4	$851K	Buy	+136,600	New	+$977K	﹤0.01%	2420
2021 Q4	–	Sell	-52,400	Closed	-$631K	–	2732
2021 Q3	$631K	Hold	52,400	–	–	﹤0.01%	2546
2021 Q2	$1.11M	Sell	52,400 -8,100	-13%	-$195K	﹤0.01%	2439
2021 Q1	$1.7M	Buy	60,500 +1,000	+2%	+$29.5K	﹤0.01%	2100
2020 Q4	$1.55M	Hold	59,500	–	–	﹤0.01%	2061
2020 Q3	$2.21M	Buy	59,500 +1,600	+3%	+$63.4K	﹤0.01%	1669
2020 Q2	$2.97M	Buy	57,900 +10,200	+21%	+$427K	﹤0.01%	1476
2020 Q1	$1.5M	Buy	47,700 +900	+2%	+$47.5K	﹤0.01%	1622
2019 Q4	$2.79M	Buy	46,800 +1,500	+3%	+$67.4K	﹤0.01%	1534
2019 Q3	$1.66M	Buy	45,300 +400	+0.9%	+$15.8K	﹤0.01%	1767
2019 Q2	$2.09M	Buy	44,900 +900	+2%	+$42.3K	﹤0.01%	1666
2019 Q1	$1.77M	Buy	44,000 +1,300	+3%	+$58.3K	﹤0.01%	1740
2018 Q4	$1.96M	Buy	42,700 +1,200	+3%	+$57.8K	﹤0.01%	1585
2018 Q3	$1.84M	Hold	41,500	–	–	﹤0.01%	1767
2018 Q2	$1.63M	Buy	41,500 +5,600	+16%	+$283K	﹤0.01%	1841
2018 Q1	$2.6M	Buy	35,900 +1,600	+5%	+$117K	﹤0.01%	1466
2017 Q4	$2.26M	Hold	34,300	–	–	﹤0.01%	1570
2017 Q3	$1.72M	Buy	34,300 +8,000	+30%	+$386K	﹤0.01%	1712
2017 Q2	$1.22M	Buy	26,300 +4,100	+18%	+$151K	﹤0.01%	1921
2017 Q1	$784K	Hold	22,200	–	–	﹤0.01%	2176
2016 Q4	$278K	Hold	22,200	–	–	﹤0.01%	2522
2016 Q3	$307K	Hold	22,200	–	–	﹤0.01%	2481
2016 Q2	$219K	Buy	22,200 +1,500	+7%	+$24.9K	﹤0.01%	2554
2016 Q1	$338K	Buy	20,700 +4,200	+25%	+$67.6K	﹤0.01%	2460
2015 Q4	$367K	Hold	16,500	–	–	﹤0.01%	2404
2015 Q3	$389K	Buy	16,500 +2,200	+15%	+$138K	﹤0.01%	2307
2015 Q2	$1.17M	Buy	14,300 +1,600	+13%	+$157K	﹤0.01%	1701
2015 Q1	$1.18M	Buy	12,700 +4,300	+51%	+$278K	﹤0.01%	1677
2014 Q4	$340K	Buy	+8,400	New	+$257K	﹤0.01%	2354

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return